中金公司参加第十一届“一带一路”高峰论坛

Hong Kong's IPO market raised more than HK$286.9 billion in 2025, reclaiming the top global ranking for IPO fundraising after several years. CICC highlighted cross-border Belt and Road financing progress, including Pakistan and Kazakhstan panda-bond mandates and the first dual listing on HKEX and the Astana International Exchange. The firm also signed cooperation memorandums with Laos-related counterparties and Uzbekistan's foreign economic activity bank covering cross-border financing, product innovation and renminbi bond issuance.

Analysis

This is directionally supportive of Hong Kong’s capital-markets ecosystem, but the direct earnings read-through for CICC (3908 HK) is likely immaterial until mandates convert into fee-bearing debt issuance, cross-border M&A, or secondary listings. The cleaner listed beneficiary is HKEX (0388 HK): incremental offshore participation in China-related primary issuance raises trading, clearing and custody revenue with substantially greater operating leverage than it does advisory revenue at any one broker. A sustained pipeline would also tighten competitive pressure on UBS, JPM and other international banks’ Asia ECM franchises, although their regional revenue exposure makes the impact modest.

The relevant mechanism is RMB internationalization rather than the announced cooperation itself. If Central Asian and Southeast Asian sovereign-linked borrowers increasingly use offshore RMB or Panda-bond formats, Hong Kong banks, custody providers and Chinese securities firms gain fee pools while CNH liquidity and hedging demand deepen; this could ultimately benefit 0388 HK more than issuers. However, nonbinding cooperation agreements are not evidence of transaction volume, and frontier-market credit risk, currency-conversion constraints, sanctions compliance, and weak secondary-market liquidity can prevent an announced framework from becoming a scalable asset class.

Near-term, this is unlikely to move prices because the information is promotional and lacks mandate size, expected issuance dates, or underwriting economics. Over 1-3 months, evidence of a disclosed sovereign or policy-bank RMB transaction, cornerstone-investor commitments, or a visible dual-listing pipeline would be a more credible catalyst for 0388 HK and 3908 HK. Over 6-18 months, the structural upside depends on whether offshore investors receive adequate disclosure, FX hedging and exit liquidity; absent those, these markets remain episodic rather than recurring fee engines.

Key Decisions for Investors

• No immediate directional trade on CICC (3908 HK): treat the announcement as an alert, not a revenue catalyst. Reassess only if the firm discloses lead-left status, deal size, fees, or a completed RMB bond/ECM mandate; falsification is continued absence of announced transactions over the next two quarters.
• Maintain a watch-list long bias in HKEX (0388 HK) for a 3-12 month capital-markets recovery, but enter only on independently observable acceleration in IPO filings, average daily turnover, or northbound/southbound flow. The key risk is a weak China equity-risk-premium backdrop that suppresses issuance despite cross-border policy activity.
• For investors seeking exposure to the theme, prefer a small 0388 HK / 3908 HK relative-value position rather than outright CICC: HKEX monetizes industry-wide issuance and turnover, while CICC bears mandate-conversion and underwriting-risk concentration. Exit if Hong Kong primary-market volumes fail to improve across two reporting periods or if fee competition compresses broker ECM margins.
• Monitor CNH funding spreads and announced Panda-bond pricing as validation signals. A widening CNH liquidity premium or repeated reliance on state-linked credit enhancement would indicate that cross-border issuance is policy-supported but not commercially scalable, weakening the broader Hong Kong-market thesis.